1 user responded in this post

Subscribe to this post comment rss or trackback url
User Gravatar
JuneauBiosciences said in March 9th, 2009 at 9:54 pm

Juneau Biosciences receives funding from angel investors. These are private individuals who are investing in this business in hopes that the research will be successful and someday a non-invasive diagnostic test will be manufactured and distributed to health care facilities across the country and around the world, at which point they will see a return on their investment. On the other hand, if the research falls through for any reason, they will not see any return.

This research is very expensive to conduct, which is why this particular company could not attempt this level of research if it were a non-profit. Between the cost of recruiting participants and obtaining the needed samples and information, and then the cost of processing each DNA sample for analysis, it is very much a process that requires a great deal of capital to work with from the get-go.

I hope this helps to clear up any confusion, and feel free to contact us if you have any further questions.